Aurora Diagnostics LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aurora Diagnostics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011858
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aurora Diagnostics LLC (Aurora Diagnostics) is a healthcare service provider that offers pathology and hospital services. The center offers pathology services which include dermatology services, gastrointestinal pathology services, heamato-pathology services, pathology consultation, urologic pathology and women’s health services. Its hospital services comprise anatomic pathology consulting, professional component development, technical component development and management services. The center operates in Alabama, Arizona, Florida, Georgia, Massachusetts, Michigan, Minnesota, Nevada, New Hampshire, New Jersey, New York, North Carolina, South Carolina, Texas and Virginia. Aurora Diagnostics is headquartered in Palm Beach Gardens, Florida, the US.

Aurora Diagnostics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aurora Diagnostics LLC, Medical Devices Deals, 2011 to YTD 2017 9
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Aurora Diagnostics Acquires Texas Hospital Pathology Practices from Brazos Valley 11
Acquisition 12
Aurora Diagnostics Acquires West Georgia Pathology 12
Aurora Diagnostics Completes Acquisition of Mid-Atlantic Pathology Services 13
Aurora Diagnostics LLC – Key Competitors 14
Aurora Diagnostics LLC – Key Employees 15
Aurora Diagnostics LLC – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Corporate Communications 18
Sep 05, 2017: Christopher Rieder Joins Aurora Diagnostics as Chief Information Officer 18
Jul 11, 2016: Aurora Diagnostics Names Michael Grattendick Chief Financial Officer 19
May 31, 2016: Dr. F. Michael Walsh Is Named Chief Medical Officer of Aurora Diagnostics 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aurora Diagnostics LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Aurora Diagnostics LLC, Medical Devices Deals, 2011 to YTD 2017 9
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aurora Diagnostics Acquires Texas Hospital Pathology Practices from Brazos Valley 11
Aurora Diagnostics Acquires West Georgia Pathology 12
Aurora Diagnostics Completes Acquisition of Mid-Atlantic Pathology Services 13
Aurora Diagnostics LLC, Key Competitors 14
Aurora Diagnostics LLC, Key Employees 15
Aurora Diagnostics LLC, Other Locations 16
Aurora Diagnostics LLC, Subsidiaries 17

★海外企業調査レポート[Aurora Diagnostics LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BioFire Diagnostics LLC:企業の製品パイプライン分析2018
    Summary BioFire Diagnostics LLC (BioFire Diagnostics), formerly Idaho Technology Inc, a subsidiary of bioMerieux SA, is a molecular diagnostics company that offers molecular biology products. The company offers solutions for healthcare providers, labs and customers. It provides respiratory, meningit …
  • Synergy:企業の戦略・SWOT・財務情報
    Synergy - Strategy, SWOT and Corporate Finance Report Summary Synergy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Rentech Inc (RTKH):企業の財務・戦略的SWOT分析
    Rentech Inc (RTKH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Suda Pharmaceuticals Ltd (SUD):企業の財務・戦略的SWOT分析
    Summary Suda Pharmaceuticals Ltd (Suda Pharmaceuticals), formerly Suda Ltd is a drug delivery company that offers oro-mucosal administration solutions. The company offers products such as SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005, artimist, and zolpimist. Its artimist is a sub-lingual spray for …
  • International Flavors & Fragrances Inc.:戦略・SWOT・企業財務分析
    International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report Summary International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Northam Platinum Limited:企業の戦略・SWOT・財務情報
    Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cutera Inc (CUTR):製品パイプライン分析
    Summary Cutera Inc (Cutera) is a medical device company that designs, manufactures and markets aesthetic devices. The company provides products that include enlighten, excel V, excel HR, truSculpt, and xeo. Its products are used in treatment of face and body medical aesthetics. Cutera’s enlighten de …
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner), a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer component …
  • Teledyne Technologies Inc (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Inc (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of several cancers including non-small cell lung cancer and pancreatic cancer. It …
  • Laing O’Rourke Australia Pty Ltd:企業の戦略的SWOT分析
    Laing O'Rourke Australia Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Merck & Co., Inc.:企業の戦略・SWOT・財務情報
    Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cavitation Technologies Inc (CVAT):企業の財務・戦略的SWOT分析
    Summary Cavitation Technologies Inc (Cavitation) is an energy service company that develops processing technologies. The company processes fluidic mixtures, liquids, emulsions and suspended solids. Its technology uses hydrodynamic cavitation that comprise fluid’s vaporization and growth, pulsation, …
  • Esperion Therapeutics Inc (ESPR):製薬・医療:M&Aディール及び事業提携情報
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Cintas Corporation:企業の戦略・SWOT・財務情報
    Cintas Corporation - Strategy, SWOT and Corporate Finance Report Summary Cintas Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • HOCHTIEF Aktiengesellschaft:企業のM&A・事業提携・投資動向
    HOCHTIEF Aktiengesellschaft - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HOCHTIEF Aktiengesellschaft Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Decas Cranberry Products, Inc.:企業の戦略・SWOT・財務情報
    Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tejas Networks Ltd (TEJASNET):企業の財務・戦略的SWOT分析
    Tejas Networks Ltd (TEJASNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Amphenol Corporation:企業の戦略・SWOT・財務情報
    Amphenol Corporation - Strategy, SWOT and Corporate Finance Report Summary Amphenol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆